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Dear Editor,
The worldwide dissemination of New Delhi metallo-β-lactamase 1
(NDM-1), an Ambler class B metallo-β-lactamase (MBL) conferring
resistance to all β-lactams except monobactams, is of great concern for
public health. NDM-4, which differs from NDM-1 by a single amino
acid substitution (Met154Leu), was demonstrated to possess increased
carbapenemase activity.1 As an infrequent blaNDM allele, only several
sporadic cases of infections due to NDM-4-producing Escherichia coli
have been described in India, Austria, and Europe.1–3 At present, only
one NDM-4 plasmid (pJEG027; GenBank accession NO KM400601)
has been characterized.4 To understand the epidemiology and control
the spread of antibiotic-resistant pathogens, we have been investigating
carbapenem-resistant Enterobacteriaceae from human patients in
China. Previously, we reported a high incidence (33.3%) and endemic
spread of NDM-1-positive Enterobacteriaceae in Henan Province.5
Here we describe the ﬁrst NDM-4-producing E. coli ST410 isolate,
which, to our knowledge, is the ﬁrst case in China, and report the
characterization of the blaNDM-4 harboring IncX3 plasmid.
E. coli 14–55 was obtained from a blood culture of a 14-year-old girl
hospitalized at The First Afﬁliated Hospital of Zhengzhou University,
Zhengzhou city, Henan province, on 6 June 2014. The girl did not
have a history of foreign travel. Susceptibility testing was initially
performed by a Vitek 2 system (bioMérieux, Marcy l'Etoile, France),
and Minimum Inhibitory Concentrations (MICs) were determined
using the broth microdilution method and the agar dilution method
(for fosfomycin) following the CLSI guidelines, and the MIC results
were interpreted according to the CLSI breakpoints.6 The European
Committee on Antimicrobial Susceptibility Testing breakpoints (avail-
able at http://www.eucast.org/clinical_breakpoints/) were used for
colistin and tigecycline. E. coli 14–55 was resistant to all β-lactams,
including imipenem and meropenem, ﬂuoroquinolones, gentamicin
and tetracycline, and was susceptible to amikacin, fosfomycin,
tigecycline and colistin (Supplementary Table S1). The modiﬁed
Hodge test and the imipenem-EDTA double-disk synergy test revealed
that E. coli 14–55 was an MBL-producer.6 PCR and sequencing were
performed to screen for the presence of MBL genes, including blaIMP,
blaNDM, and blaVIM; only blaNDM was detected.
5 The complete coding
sequence (CDS) of blaNDM was ampliﬁed with a pair of primers
(NDM-F: 5′-GAA TTC GCC CCA TAT TTT TGC; NDM-R:
5′-AAC GCC TCT GTC ACA TCG AAA T) that ﬂanked the blaNDM
gene, and DNA sequencing revealed the presence of blaNDM-4 in E. coli
14–55. In addition, different β-lactamase encoding genes, including
blaCTX-M-15, blaSHV-12, blaTEM-1 and blaCMY-61, together with the qnrB
gene were identiﬁed in the NDM-4 positive isolate E. coli 14–55.5
E. coli phylogenetic group typing and multilocus sequence typing
(MLST) showed that the isolate E. coli 14–55 belonged to phylogroup
A and ST410.5,7 At present, ﬁve E. coli STs (India: ST648; Italy and
Denmark: ST405; Austria: ST167, ST4450, and ST101) have been
identiﬁed carrying blaNDM-4 worldwide.
1–3 Thus, this study represents
the ﬁrst report of ST410 as a carrier of blaNDM-4. Notably, recent
publications from Germany and Italy described the clonal expansion
of ﬂuoroquinolone (FQ)-resistant CTX-M-15-producing E. coli ST410
in both human and animal populations.8,9 Our previous and current
studies also identiﬁed E. coli ST410 clinical isolates co-harboring
multiple resistance determinants, including blaNDM (blaNDM-1/4),
ESBLS (blaCTX-M-15, blaSHV-12/blaTEM-1) and ampC genes (blaCMY-30/
blaCMY-61).
5 In addition, NDM-5 producing E. coli ST410 was recently
detected in Egypt.10 These ﬁndings suggest that E. coli ST410 might be
an emerging pandemic clone similar to ST131 for the dissemination of
CTX-M-15 or NDM encoding genes. This possibility remains to be
examined from future surveillance work.
S1-PFGE and PCR-based plasmid replicon typing indicated
E. coli 14–55 harbored three different plasmids that belonged to the
IncX3, IncFIA and IncFIB incompatibility groups.5,11 (Supplemen-
tary Figure S1). Southern hybridization using digoxigenin-labeled
blaNDM-1-speciﬁc probes (Roche Applied Sciences, Germany) showed
that blaNDM-4 was located on an approximately 50 kb plasmid in
E. coli 14–55 (Supplementary Figure S1). Although the conjugal
transfer of plasmids for E. coli 14–55 failed, the NDM-4
carrying plasmid belonging to the IncX3 incompatibility group was
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successfully transformed into E. coli DH5α Electro-Cells (TaKaRa,
Dalian, China) by electroporation (Supplementary Figure S1).
MICs for the transformant (named T55 in this study) are summarized
in (Supplementary Table S1). To characterize the IncX3-type
NDM plasmid, 12 pairs of primers were designed based on
a reference IncX3 plasmid named pNDM-HN380 (NC_019162)
for the mapping of the backbone regions (Supplementary
Table S2), and the MDR regions were characterized by a primer
walking method.
The blaNDM-4 harboring plasmid in E. coli 14–55 (named pEC55-
NDM-4) is 54 035 bp in size, with an average G+C content of 49.1%.
The sequence data revealed that pEC55-NDM-4 is highly similar
(499.99%) to plasmid pNDM-HN380, which is the ﬁrst characterized
blaNDM-1-harboring IncX3 plasmid of Klebsiella pneumoniae ST483
and was isolated in Hong Kong, with nucleotide changes from G to A
at bp 4447, from T to G at 18 179 bp, from G to A at 21 656 bp, and
from C to T at 23 844 bp (Figure 1).12 The point mutation at position
T18,179 G corresponds to the A460C mutation in blaNDM-1, leading to
the occurrence of the blaNDM-4 allele. A comparative plasmid analysis
between pEC55-NDM-4 and pJEG027, which is the only completely
sequenced NDM-4 plasmid of a K. pneumoniae strain isolated in
Austria, provided support for Espedido et al’s hypothesis that pJEG027
might have arisen from a pNDM-HN380-like plasmid ancestor (for
example, pEC55-NDM-4) through the events of a different IS5
insertion and an IS26-mediated ﬂanking deletion of cutA1-groL.4
Several recent studies revealed that the blaNDM-4 gene was carried by
plasmids belonging to different replicon types, including F, FII, L/M
and X3 in E. coli and K. pneumoniae; however, only two partial
sequences of IncFII plasmids (accession NO KP826711 and
KP826707) and one partial sequence of an IncX3 plasmid (accession
NO KP826709) except pJEG027 are available for the genetic context of
blaNDM-4.
2,3,13 The second completely sequenced blaNDM-4 carrying
plasmid pEC55-NDM-4, in our study, is nearly identical to the ﬁrst
characterized blaNDM-1-harboring IncX3 plasmid pNDM-HN380,
further suggesting that blaNDM-4 might have emerged on IncX3
plasmids via a point mutation in blaNDM-1. The occurrence of a
pNDM-HN380-like plasmid carrying blaNDM-4, in this study, together
with recent observations of IncX3-type plasmids carrying different
blaNDM alleles, including blaNDM-1 (pNDM-HN380), blaNDM-4
(pJEG027), blaNDM-5 (pNDM_MGR194, pNDM5_0215 and
pEc1929), and blaNDM-7 (pEC50-NDM7), in different countries
(Austria, India, China and Canada) and different species (K. pneu-
moniae, E. coli, Serratia marcescens, and Enterobacter hormae-
chei),4,12,14,15 strongly indicates that IncX3 plasmids, which have a
narrow host range in Enterobacteriaceae, might have played a major
role in the rapid global dissemination of NDM-type MBLs among
Enterobacteriaceae.
In summary, our study represents the ﬁrst report of a NDM-4
producing E. coli isolate recovered from a blood culture of a patient
without a history of foreign travel. The FQ-resistant E. coli 14–55 with
multiple β-lactamase encoding genes, including blaNDM-4, blaCTX-M-15,
blaSHV-12, blaTEM-1 and blaCMY-61, belonged to ST410, a potential
international clone for the dissemination of CTX-M-15. Further
surveillance is thus warranted to monitor the future dissemination
of potentially endemic clones of ST410 that harbor blaNDM. The
blaNDM-4 carrying IncX3 plasmid characterized in this study is nearly
identical to pNDM-HN380 (with blaNDM-1), which was reported in
Hong Kong. This ﬁnding, together with recent observations of IncX3
plasmids carrying different blaNDM alleles in different countries,
further suggests that IncX3 plasmids might have become a common
vehicle for the dissemination of different NDM alleles among
Enterobacteriaceae worldwide.
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Figure 1 Comparison of linear plasmid maps of IncX3 plasmids harboring blaNDM: pNDM-HN380 (blaNDM-1, JX104760), pEC55-NDM-4 (blaNDM-4,
KX470734), pJE027 (blaNDM-4, KM400601). Light gray shading indicates homologous regions, while dark gray shading indicates inversely displayed regions
of homology. The different arrows indicate the positions, directions of transcription and predicted function of the genes.
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